Allison Barraclough
-
- Lymphoma Diagnosis and Treatment 23
-
- CAR-T cell therapy research 13
- Viral-associated cancers and disorders 5
- Cancer Immunotherapy and Biomarkers 3
-
- Chronic Lymphocytic Leukemia Research 5
-
- CNS Lymphoma Diagnosis and Treatment 2
-
- Monoclonal and Polyclonal Antibodies Research 5
-
- Sarcoma Diagnosis and Treatment 3
Allison Barraclough
21 papers receiving 152 citations
Peers
Comparison fields: 5 of 39
- Pathology and Forensic Medicine 106
- Oncology 87
- Genetics 30
- Neurology 35
- Immunology 20
Countries citing papers authored by Allison Barraclough
This map shows the geographic impact of Allison Barraclough's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allison Barraclough with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allison Barraclough more than expected).
Fields of papers citing papers by Allison Barraclough
This network shows the impact of papers produced by Allison Barraclough. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allison Barraclough. The network helps show where Allison Barraclough may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Allison Barraclough, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 0 | |
| 6 | 2025 | 0 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 2 | |
| 9 | 2024 | 2 | |
| 10 | 2024 | 0 | |
| 11 | 2024 | 1 | |
| 12 | 2023 | 3 | |
| 13 | 2023 | 11 | |
| 14 | 2023 | 13 | |
| 15 | 2019 | 28 | |
| 16 | 2019 | 1 | |
| 17 | 2019 | 7 | |
| 18 | 2017 | 0 | |
| 19 | 2012 | 7 | |
| 20 | 2011 | 2 |
About Allison Barraclough
Allison Barraclough is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics, having authored 29 papers that have together received 152 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (23 papers), CAR-T cell therapy research (13 papers), Chronic Lymphocytic Leukemia Research (5 papers), Viral-associated cancers and disorders (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Cancer Immunotherapy and Biomarkers (3 papers), Sarcoma Diagnosis and Treatment (3 papers) and CNS Lymphoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (106 citations), Oncology (87 citations) and Genetics (30 citations). Allison Barraclough has collaborated with scholars based in Australia, Canada and Denmark. Frequent co-authors include Eliza A. Hawkes, Laurie H. Sehn, Diego Villa, Mark Bishton, Chan Y. Cheah, Geoffrey Chong, Sonali M. Smith, Leonid Churilov, Andrew Grigg and Colm Keane. Their work appears in journals such as Journal of Clinical Oncology, Blood and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.